Cargando…
Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study)
INTRODUCTION: This study aimed to assess the clinical, economic, and humanistic impact of short-bowel syndrome/chronic intestinal failure (SBS/CIF) in Portugal. METHODS: This is a retrospective multicenter cohort chart review study, with a cross-sectional component for quality-of-life (QoL) evaluati...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521323/ https://www.ncbi.nlm.nih.gov/pubmed/37767305 http://dx.doi.org/10.1159/000526059 |
_version_ | 1785110104776900608 |
---|---|
author | Silva, Raul Guerra, Paula Rocha, Anabela Correia, Miguel Ferreira, Ricardo Fonseca, Jorge Lima, Eduardo Oliveira, António Vargas Gomes, Marta Ramos, Diogo Andreozzi, Valeska Santos, Marisa D. |
author_facet | Silva, Raul Guerra, Paula Rocha, Anabela Correia, Miguel Ferreira, Ricardo Fonseca, Jorge Lima, Eduardo Oliveira, António Vargas Gomes, Marta Ramos, Diogo Andreozzi, Valeska Santos, Marisa D. |
author_sort | Silva, Raul |
collection | PubMed |
description | INTRODUCTION: This study aimed to assess the clinical, economic, and humanistic impact of short-bowel syndrome/chronic intestinal failure (SBS/CIF) in Portugal. METHODS: This is a retrospective multicenter cohort chart review study, with a cross-sectional component for quality-of-life (QoL) evaluation. Inclusion criteria comprised patients with SBS/CIF, aged ≥1 year, with stable parenteral nutrition (PN). Data collection included patient chart review over a 12-month period and patient/caregiver self-report and SF-36/PedsQL™ questionnaires. Main endpoints comprised clinical and PN characterization, healthcare resource use (HRU), direct costs, and patient QoL. RESULTS: Thirty-one patients were included (11 adults and 20 children). Patients' mean age (standard deviation [SD]) was 57.9 (14.3) years in adults and 7.5 (5.0) years in children, with a mean time since diagnosis of 10.2 (5.9) and 6.6 (4.2) years, respectively. PN was administered for a mean of 5.2 and 6.6 days/week in adults and children, respectively; home PN occurred in 81.8% of adults and 90.0% of children for a mean of 9.6 and 10.8 months/year, respectively. The mean annual number of hospitalizations was 1.9 and 2.0 which lasted for a mean of 34.0 and 29.4 days in adults and children, respectively. Twenty-one and forty hospitalization episodes were reported in adults and children, respectively, of which 71.4% and 85.0% were due to catheter-related complications. Mean annual direct costs per patient amounted to 47,857.53 EUR in adults and 74,734.50 EUR in children, with PN and hospitalizations as the main cost-drivers. QoL assessment showed a clinically significant impaired physical component in adults and a notable deterioration in the school functioning domain in children. CONCLUSION: In Portugal, SBS/CIF patient management is characterized by a substantial therapeutic burden and HRU, translating into high direct costs and a substantial impairment of the adults' physical function and children's school functioning. |
format | Online Article Text |
id | pubmed-10521323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-105213232023-09-27 Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study) Silva, Raul Guerra, Paula Rocha, Anabela Correia, Miguel Ferreira, Ricardo Fonseca, Jorge Lima, Eduardo Oliveira, António Vargas Gomes, Marta Ramos, Diogo Andreozzi, Valeska Santos, Marisa D. GE Port J Gastroenterol Research Article INTRODUCTION: This study aimed to assess the clinical, economic, and humanistic impact of short-bowel syndrome/chronic intestinal failure (SBS/CIF) in Portugal. METHODS: This is a retrospective multicenter cohort chart review study, with a cross-sectional component for quality-of-life (QoL) evaluation. Inclusion criteria comprised patients with SBS/CIF, aged ≥1 year, with stable parenteral nutrition (PN). Data collection included patient chart review over a 12-month period and patient/caregiver self-report and SF-36/PedsQL™ questionnaires. Main endpoints comprised clinical and PN characterization, healthcare resource use (HRU), direct costs, and patient QoL. RESULTS: Thirty-one patients were included (11 adults and 20 children). Patients' mean age (standard deviation [SD]) was 57.9 (14.3) years in adults and 7.5 (5.0) years in children, with a mean time since diagnosis of 10.2 (5.9) and 6.6 (4.2) years, respectively. PN was administered for a mean of 5.2 and 6.6 days/week in adults and children, respectively; home PN occurred in 81.8% of adults and 90.0% of children for a mean of 9.6 and 10.8 months/year, respectively. The mean annual number of hospitalizations was 1.9 and 2.0 which lasted for a mean of 34.0 and 29.4 days in adults and children, respectively. Twenty-one and forty hospitalization episodes were reported in adults and children, respectively, of which 71.4% and 85.0% were due to catheter-related complications. Mean annual direct costs per patient amounted to 47,857.53 EUR in adults and 74,734.50 EUR in children, with PN and hospitalizations as the main cost-drivers. QoL assessment showed a clinically significant impaired physical component in adults and a notable deterioration in the school functioning domain in children. CONCLUSION: In Portugal, SBS/CIF patient management is characterized by a substantial therapeutic burden and HRU, translating into high direct costs and a substantial impairment of the adults' physical function and children's school functioning. S. Karger AG 2022-09-08 /pmc/articles/PMC10521323/ /pubmed/37767305 http://dx.doi.org/10.1159/000526059 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Research Article Silva, Raul Guerra, Paula Rocha, Anabela Correia, Miguel Ferreira, Ricardo Fonseca, Jorge Lima, Eduardo Oliveira, António Vargas Gomes, Marta Ramos, Diogo Andreozzi, Valeska Santos, Marisa D. Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study) |
title | Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study) |
title_full | Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study) |
title_fullStr | Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study) |
title_full_unstemmed | Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study) |
title_short | Clinical, Economic, and Humanistic Impact of Short-Bowel Syndrome/Chronic Intestinal Failure in Portugal (PARENTERAL Study) |
title_sort | clinical, economic, and humanistic impact of short-bowel syndrome/chronic intestinal failure in portugal (parenteral study) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521323/ https://www.ncbi.nlm.nih.gov/pubmed/37767305 http://dx.doi.org/10.1159/000526059 |
work_keys_str_mv | AT silvaraul clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy AT guerrapaula clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy AT rochaanabela clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy AT correiamiguel clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy AT ferreiraricardo clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy AT fonsecajorge clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy AT limaeduardo clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy AT oliveiraantonio clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy AT vargasgomesmarta clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy AT ramosdiogo clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy AT andreozzivaleska clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy AT santosmarisad clinicaleconomicandhumanisticimpactofshortbowelsyndromechronicintestinalfailureinportugalparenteralstudy |